DURMAZ, L. Et Al. 2023. Potential antioxidant, anticholinergic, antidiabetic and antiglaucoma activities and molecular docking of spiraeoside as a secondary metabolite of onion (Allium cepa). Saudi Pharmaceutical Journal , vol.31, no.10 .

DURMAZ, L., Kızıltaş, H., Karagecili, H., Alwasel, S., & GÜLÇİN, İ., (2023). Potential antioxidant, anticholinergic, antidiabetic and antiglaucoma activities and molecular docking of spiraeoside as a secondary metabolite of onion (Allium cepa). Saudi Pharmaceutical Journal , vol.31, no.10.

DURMAZ, LOKMAN Et Al. "Potential antioxidant, anticholinergic, antidiabetic and antiglaucoma activities and molecular docking of spiraeoside as a secondary metabolite of onion (Allium cepa)," Saudi Pharmaceutical Journal , vol.31, no.10, 2023

DURMAZ, LOKMAN Et Al. "Potential antioxidant, anticholinergic, antidiabetic and antiglaucoma activities and molecular docking of spiraeoside as a secondary metabolite of onion (Allium cepa)." Saudi Pharmaceutical Journal , vol.31, no.10, 2023

DURMAZ, L. Et Al. (2023) . "Potential antioxidant, anticholinergic, antidiabetic and antiglaucoma activities and molecular docking of spiraeoside as a secondary metabolite of onion (Allium cepa)." Saudi Pharmaceutical Journal , vol.31, no.10.

@article{article, author={LOKMAN DURMAZ Et Al. }, title={Potential antioxidant, anticholinergic, antidiabetic and antiglaucoma activities and molecular docking of spiraeoside as a secondary metabolite of onion (Allium cepa)}, journal={Saudi Pharmaceutical Journal}, year=2023}